Archer Materials’ CEO Simon Ruffell sat down with ausbiz at the Semiconductor Australia 2025 conference to talk about the progress on its suite of quantum technologies.
Simon spoke to how the team is de-risking the Biochip clinical trials for regulatory approval and forming its pathway to commercialisation. He also discussed quantum’s importance in advancing technology, Archer’s partnerships, key catalysts to look for, plus much more.
See the interview here
Get the latest updates on our breakthrough technologies and research developments. Join thousands of researchers, investors, and technology enthusiasts.
